Reproductive Medicine Center, Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China (mainland).
Med Sci Monit. 2021 Feb 10;27:e928737. doi: 10.12659/MSM.928737.
BACKGROUND This study investigated the effectiveness and feasibility of day 4 (D4) morula embryo transfer (ET) in comparison with day 5 (D5) blastocyst ET, with regards to their clinical data, laboratory test results, and pregnancy outcomes. MATERIAL AND METHODS This retrospective cohort study enrolled 1070 patients, including 178 cases in group D4 and 892 cases in group D5. The endpoint was live birth rate after fresh embryo transfer. Furthermore, the clinical outcomes of D4 embryos with different morphology were compared and assigned to 3 groups: in group 1 (n=66) the embryos were compacted but not expanded, in group 2 (n=102) the embryos were compacted and expanded (early blastocyst), and in group 3 (n=10) the embryos were not compacted. RESULTS Groups D4 and D5 had comparable clinical pregnancy rates (53.37% vs. 59.97%) and live birth rates (43.25% vs 50.89%), and there were no significant differences between the 2 groups. In group 3, there was only 1 clinical pregnancy and no live birth. In comparison between group 1 and group 2, the clinical pregnancy rate of group 2 showed an upward trend (48.48% vs 60.78%), but there was no significant difference. There was also no statistically significant difference in the live birth rate between the 2 groups (42.42% vs 49.01%). CONCLUSIONS Transferring of compacted embryos or early blastocysts can result in high clinical pregnancy rates and live birth rates. In addition to the cleavage and blastocyst ET, morula ET may serve as an alternative option for the clinician.
本研究旨在比较第 4 天(D4)桑椹胚与第 5 天(D5)囊胚移植的有效性和可行性,主要比较两组的临床资料、实验室检查结果和妊娠结局。
本回顾性队列研究纳入了 1070 例患者,其中 D4 组 178 例,D5 组 892 例。研究的终点为新鲜胚胎移植后的活产率。此外,还比较了不同形态 D4 胚胎的临床结局,并将其分为 3 组:第 1 组(n=66)的胚胎致密但未扩张,第 2 组(n=102)的胚胎致密且扩张(早期囊胚),第 3 组(n=10)的胚胎未致密。
D4 组和 D5 组的临床妊娠率(53.37% vs. 59.97%)和活产率(43.25% vs. 50.89%)相当,两组间无显著差异。第 3 组仅 1 例临床妊娠,无活产。与第 1 组相比,第 2 组的临床妊娠率呈上升趋势(48.48% vs. 60.78%),但差异无统计学意义。两组的活产率也无统计学差异(42.42% vs. 49.01%)。
移植致密胚胎或早期囊胚可获得较高的临床妊娠率和活产率。除了卵裂期和囊胚期胚胎移植外,桑椹胚移植也可作为临床医生的另一种选择。